ARC Centre of Excellence in Quantum Biotechnology
The ARC Centre of Excellence in Quantum Biotechnology aims to develop paradigm-shifting quantum technologies to observe biological processes and transform our understanding of life. It seeks to create technologies that go far beyond what is possible today, from portable brain imagers to super-fast single protein sensors, and to use them to unravel key problems including how enzymes catalyse reactions and how higher brain function emerges from networks of neurons. By building a diverse, multidisciplinary, and industry-engaged ecosystem, the Centre means to develop our future leaders at the interface of quantum science and biology and drive Australian innovation across manufacturing, energy, agriculture, health, and national security.
Funding: $35 million over 7 years
Centre Director: Prof Warwick Bowen
Administering Organisation: The University of Queensland
Participating Organisations:
- The University of Melbourne
- Flinders University
- University of Technology Sydney
- University of Wollongong
- OLYMPUS AUSTRALIA PTY LTD
- IBM Corporation
- GENIEUS GENOMICS PTY LIMITED
- Q-CTRL PTY LTD
- Intelligent Imaging Innovations, Inc.
- ELEMENTAL INSTRUMENTS PTY LTD
- ORICA AUSTRALIA PTY LTD
- SILANNA SEMICONDUCTOR PTY LTD
- Protein Evolution Ltd.
- Defence Science and Technology Group
- Commonwealth Scientific and Industrial Research Organisation
- Department of Environment and Science
- Massachusetts Institute of Technology
- University of California, Berkeley
- University of Ulm
- French National Centre for Scientific Research
- University of Victoria, Canada
- University of Exeter, UK
- University of Surrey
- University of California, Irvine
- University of Glasgow, UK
- University of Michigan, Ann Arbor, Michigan US
- Medical University of Innsbruck
- Delft University of Technology, Netherlands
- University of Stuttgart
- Johns Hopkins University